Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

September 2013 Issue of The Ophthalmologist

Register to download

Register here to download any issue of The Ophthalmologist for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Business & Profession Other

A Fresh Perspective

| Richard Gallagher

Focusing on ophthalmologists rather than just on ophthalmology will generate an engaging, accessible and, above all, useful new publication.

Business & Profession Professional Development

Ophthalmology Service in UK “Failing”, Says Report

| Mark Hillen

A stark picture of an overstretched, fragile service, often at odds with hospital management, is painted in a recent RCO report. What can be done?

Business & Profession Glaucoma

Glaucoma from the patient's perspective.

| Sophia Ktori

Free glaucoma simulation app reinforces the importance of taking medication. A recently-launched free app for iPhones and iPads will help newly diagnosed glaucoma patients better understand how the condition will affect their vision as it worsens, reinforcing the importance of taking prescribed eye drops and attending eye clinic.

Business & Profession Professional Development

Big Pharma Loves Ophtho

| Mark Hillen

Why the pharmaceutical industry is making acquisitions in ophthalmology – and why it won’t stop. The world’s pharmaceutical companies have fallen heavily for the charms of ophthalmology in recent times, with a string of acquisitions and product launches, including:

Subspecialties Retina

Retinal Images Predict Future Stroke Risk

| Sophia Ktori

The level of hypertensive retinopathy is an independent long-term risk factor. A recent study has demonstrated that retinal photographs can reveal the future stroke risk of hypertensive patients –

Business & Profession Other

Eyeball Licking: What If…

| Grace Willatt

In the event of an oculolinctus craze, we are ready (thanks to The Daily Mail and others). This summer, Western media leapt upon a post on Japanese curation site Naver Matome which detailed a sudden increase in the practice of oculolinctus.

Business & Profession Retina

In the Eye of the Storm

| Mark Zacharria

The global obesity pandemic is causing a chronic cardiovascular and diabetic disease crisis. Advances in retinal microvascular imaging offer hope in tackling these problems… but are ophthalmologists ready for a prominent role in the fight against systemic disease?

Subspecialties Cornea / Ocular Surface

Constructive Cross-Links

| Arthur Cummings

Corneal cross-linking (CXL) is having a transformative impact on the treatment of keratoconus and post-laser ectasia.

Subspecialties Retina

An Intrepid Assault on AMD

| Mark Shusterman

Stereotactic radiation therapy is a new treatment aimed at wet age-related macular degeneration. The results of a randomized, sham-controlled trial are encouraging.

Subspecialties Glaucoma

BAK Off

| Mark Hillen

Is the future of eyedrops preservative-free? Itching. Irritation. Dry eye. In extreme cases, keratosis and scarring. Adverse events occur in one in 10 patients who are on long-term therapy with eyedrops for conditions like glaucoma or uveitis. For many, these side-effects are caused by preservatives.

Subspecialties Glaucoma

Pediatric Glaucoma, East and West

| Nadir Bayoumi

Management approaches for best outcome vary by location. Glaucoma is exceeded only by cataracts as a cause of blindness. In 2002, the World Health Organization estimated that 12.3 million people worldwide had been blinded by glaucoma.

Subspecialties Cornea / Ocular Surface

To Galen, Mundinus and Tulp, Add Dua

| Harminder Dua

It’s a rare discovery that necessitates changes to anatomy textbooks. Here, Harminder Dua describes how he discovered the eponymous new layer of the cornea, and discusses its significance.

Business & Profession Retina

Seeing the Unseeable

| Eberhart Zrenner

Retinal implants offer hope for the treatment of inherited blindness. Clinical trials of battery-powered subretinal and epiretinal devices have demonstrated that patients with retinitis pigmentosa, blind for many years, can once again recognize objects.

Business & Profession Other

The Vitreous Proteome

| Mark Hillen

Well over 1,000 different proteins have been cataloged in the vitreous humor. Here’s how they break down.

Business & Profession Professional Development

Building a Presbyopia Practice

| Jeff Machat, Sondra Black

With an ever-growing market and new treatment options on hand, presbyopia offers an attractive business proposition. Understanding the patient and building your practice around her/him is key to success. Here’s how we have done it.

Subspecialties Glaucoma

Glaucoma Tug-of-War

| David Andrews

In Australia, the highly successful collaborative care approach for glaucoma patients has been ripped apart by the optometrists’ regulatory body. Can it be repaired? Ophthalmologists are making a determined effort.

Business & Profession Glaucoma

Under Pressure

| Mark Hillen

How do you translate a good idea into a physical, purchasable product? Technical, medical, regulatory and business skills are a must, as is an immense ability to resist pressure – especially when your device measures it.

Business & Profession Professional Development

The Eminence of Eye Tech

| Rolf Schwind

What is SCHWIND eye-tech-solutions known for? We develop, produce and market a comprehensive product portfolio for the treatment of ametropia and corneal diseases. This includes diagnostic systems, software modules for individual treatment planning, and nanosecond and excimer laser systems.

Subspecialties Cornea / Ocular Surface

Case Study on a Dry Eye Patient: Keratograph 5M Topographer with additional features

Dry Eye Disease (DED) is one of the most common problems that we deal with in our clinics. We have seen our dry eye clinic grow exponentially as the baby boomers become older. We completed a 3 year retrospective study showing that over 75%

Subspecialties Imaging & Diagnostics

The new MACH2 Vitreous Cutter with Double-Blade Technology

During the DOC 2013 in Nürnberg/Germany the new Geuder MACH2 Double-Blade Vitreous Cutter was introduced. For the first time, the technology of two active blades has been realized in a sterile product.

Other issues of 2013